Cancer research

GSK and Oxford University Collaborate on Cancer Vaccines

GSK and the University of Oxford have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The program, in which GSK plans to invest up to £50 million over a minimum of three years, will conduct translational research, exploring precancer biology to generate key insights on how cancer develops in humans that could inform future development of cancer vaccines.

News

Boehringer Ingelheim Expands Cancer Research at Vienna Site

On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.

News

Genome Study Brings Blood Cancer Into Sharp Focus

Top-Feature

Sasol

Leading Transformation

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Dow Chemical Company

Anchored in Sustainability

Together for Sustanability (TFS)

Driving Sustainability Through Collaboration

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

WuXi AppTec

Europe’s Biotech Inflection Point

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Easyfairs Deutschland GmbH

Leading the way. Driving results.

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.